<?xml version="1.0" standalone="no"?>
<!DOCTYPE ALGORITHM SYSTEM
  "http://sierra2.stanford.edu/sierra/ASI2.1.dtd">

<!-- ANRS algorithm (version 33 Oct 2022) in XML format -->
<!--
History:
18-OCT-22 PT Updated algorithm based on https://hivfrenchresistance.org/wp-content/uploads/2022/10/algo-2022-V33.pdf
18-OCT-22 PT Updated algorithm based on https://hivfrenchresistance.org/hiv-french-resitance-tables-of-rules-2021/
18-OCT-22 PT Updated algorithm based on https://hivfrenchresistance.org/hiv-french-resitance-tables-of-rules-2/
21-JAN-20 KMT Updated algorithm based on http://www.hivfrenchresistance.org/2019/Algo-nov2019-HIV1.pdf
10-JAN-19 PT Updated algorithm based on http://www.hivfrenchresistance.org/2018b/Algo-nov2018-HIV1.pdf
08-JUN-18 PT Updated algorithm based on http://www.hivfrenchresistance.org/2018/Algo2018-hiv1.pdf
15-JAN-18 RS updated DTG (creating low and high as well as just DTG which is low) and DRV (low and high and just DRV which is low)
03-JAN-18 RS & PT Updated algorithm based on http://www.hivfrenchresistance.org/2017/Algo2017-hiv1.pdf
05-JAN-17 RS & PT Updated algorithm based on http://www.hivfrenchresistance.org/2016/Algo2016-hiv1.pdf
20-FEB-14 TFL Updated algorithm based on http://www.hivfrenchresistance.org/2013/Algo-sep-2013.pdf
21-MAR-13 TFL Updated algorithm based on http://www.hivfrenchresistance.org/2012/tab1.html
11-JAN-11 TFL Updated algorithm based on http://www.medpocket.com/ as of JUL-2010
13-OCT-09 TFL Updated algorithm based on http://www.medpocket.com/ as of 13-OCT-2009
29-SEP-08 TFL Updated algorithm based on http://www.hivfrenchresistance.org/2008/tab4.html
01-OCT-07 TFL Updated algorithm based on the PDF version
12-SEP-07 TFL Updated algorithm
18-SEP-06 TFL Corrected algorithm
08-AUG-06 MJO Updated algorithm
06-SEP-04 TFL Updated algorithm
25-OCT-04 TFL Updated algorithm
11-JAN-04 TFL Updated algorithm
08-NOV-03 TFL Updated algorithm
06-JUL-02 BBE Added comment to DDC.
13-NOV-01 BBE Added the history comment block.
20-OCT-01 BBE Creation
-->

<ALGORITHM>
     <ALGNAME>ANRS</ALGNAME>
     <ALGVERSION>33</ALGVERSION>
     <ALGDATE>2022-10-01</ALGDATE>

     <DEFINITIONS>
    	<GENE_DEFINITION>
    	   <NAME>PR</NAME>
    	   <DRUGCLASSLIST>PI</DRUGCLASSLIST>
    	</GENE_DEFINITION>

    	<GENE_DEFINITION>
    	   <NAME>RT</NAME>
    	   <DRUGCLASSLIST>NNRTI, NRTI</DRUGCLASSLIST>
    	</GENE_DEFINITION>

    	<GENE_DEFINITION>
    	   <NAME>IN</NAME>
    	   <DRUGCLASSLIST>INSTI</DRUGCLASSLIST>
    	</GENE_DEFINITION>

    	<GENE_DEFINITION>
    	   <NAME>GP41</NAME>
    	   <DRUGCLASSLIST>EIGP41</DRUGCLASSLIST>
    	</GENE_DEFINITION>

    	<GENE_DEFINITION>
    	   <NAME>GP120</NAME>
    	   <DRUGCLASSLIST>EIGP120</DRUGCLASSLIST>
    	</GENE_DEFINITION>

      <GENE_DEFINITION>
    	   <NAME>CA</NAME>
    	   <DRUGCLASSLIST>CAI</DRUGCLASSLIST>
    	</GENE_DEFINITION>

         <LEVEL_DEFINITION>
             <ORDER>1</ORDER>
             <ORIGINAL>Susceptible</ORIGINAL>
             <SIR>S</SIR>
         </LEVEL_DEFINITION>

         <LEVEL_DEFINITION>
             <ORDER>2</ORDER>
             <ORIGINAL>Possible resistance</ORIGINAL>
             <SIR>I</SIR>
         </LEVEL_DEFINITION>

         <LEVEL_DEFINITION>
             <ORDER>3</ORDER>
             <ORIGINAL>Resistance</ORIGINAL>
             <SIR>R</SIR>
         </LEVEL_DEFINITION>

         <DRUGCLASS>
             <NAME>PI</NAME>
             <DRUGLIST>LPV/r,ATV/r,DRV/r_QD,DRV/r_BID</DRUGLIST>
         </DRUGCLASS>

         <DRUGCLASS>
             <NAME>NRTI</NAME>
             <DRUGLIST>AZT,3TC,FTC,ABC,TDF,TAF,ISL</DRUGLIST>
         </DRUGCLASS>

         <DRUGCLASS>
             <NAME>NNRTI</NAME>
             <DRUGLIST>NVP,EFV,ETR,RPV,DOR</DRUGLIST>
         </DRUGCLASS>

         <DRUGCLASS>
             <NAME>EIGP41</NAME>
             <DRUGLIST>ENF</DRUGLIST>
         </DRUGCLASS>

         <DRUGCLASS>
             <NAME>EIGP120</NAME>
             <DRUGLIST>FTR</DRUGLIST>
         </DRUGCLASS>

         <DRUGCLASS>
             <NAME>INSTI</NAME>
             <DRUGLIST>RAL,EVG,DTG_QD,DTG_BID,CAB,BIC</DRUGLIST>
         </DRUGCLASS>

         <DRUGCLASS>
             <NAME>CAI</NAME>
             <DRUGLIST>LEN</DRUGLIST>
         </DRUGCLASS>

     </DEFINITIONS>

<!-- ********** Begin NRTI drugs ********** -->

     <DRUG>
         <NAME>AZT</NAME>
         <FULLNAME>zidovudine</FULLNAME>
         <RULE>
             <CONDITION>
                 215ACDEGHILNSVYF
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 3 FROM (41L,67N,70R,210W,219QE)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 69i
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
    </DRUG>
     <DRUG>
         <NAME>3TC</NAME>
         <FULLNAME>lamivudine</FULLNAME>
         <RULE>
             <CONDITION>
                 65R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 184VI
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 69i
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>

     <DRUG>
         <NAME>FTC</NAME>
         <FULLNAME>emtricitabine</FULLNAME>
         <RULE>
             <CONDITION>
                 65R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 184VI
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 69i
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>

     <DRUG>
         <NAME>ABC</NAME>
         <FULLNAME>abacavir</FULLNAME>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 3 FROM (41L,67N,184VI,210W,215ACDEGHILNSVYF)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 65R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 74VI
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 115F
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 69i
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 2 AND NOTMORETHAN 2 FROM (41L,67N,210W,215ACDEGHILNSVYF)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
          <RULE>
             <CONDITION>
                 184VI
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>
     <DRUG>
         <NAME>TDF</NAME>
         <FULLNAME>tenofovir</FULLNAME>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 4 FROM (41L,44D,67N,69DNS,74VI,210W,215ACDEGHILNSVYF)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 65REN
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 69i
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 70E
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 3 AND NOTMORETHAN 3 FROM (41L,44D,67N,69DNS,74VI,210W,215ACDEGHILNSVYF)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>
     <DRUG>
         <NAME>TAF</NAME>
         <FULLNAME>tenofovir alafenamide</FULLNAME>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 4 FROM (41L,44D,67N,69DNS,74VI,210W,215ACDEGHILNSVYF)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 65REN
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 69i
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 70E
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 3 AND NOTMORETHAN 3 FROM (41L,44D,67N,69DNS,74VI,210W,215ACDEGHILNSVYF)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>
     <DRUG>
       <NAME>ISL</NAME>
       <FULLNAME>islatravir</FULLNAME>
       <RULE>
         <CONDITION>
           184VI
         </CONDITION>
         <ACTIONS>
           <LEVEL>3</LEVEL>
         </ACTIONS>
       </RULE>
       <RULE>
         <CONDITION>
           114S
         </CONDITION>
         <ACTIONS>
           <LEVEL>2</LEVEL>
         </ACTIONS>
       </RULE>
     </DRUG>

<!-- ********** Begin NNRTI drugs ********** -->

     <DRUG>
         <NAME>EFV</NAME>
         <FULLNAME>efavirenz</FULLNAME>
         <RULE>
             <CONDITION>
                 100I
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 101E
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 103HNST
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 106M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 138K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 181CI
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 188CL
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 190ACEQSTV
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 225H
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 230L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>

     <DRUG>
         <NAME>NVP</NAME>
         <FULLNAME>nevirapine</FULLNAME>
         <RULE>
<!--  "résistance" for HIV-1 subtype C and "résistance possible" for HIV-1 other than subtype C; Deshpande A et al. Resistance mutations in subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure: resistance to AR. AIDS Res Hum Retroviruses 2007; 23 : 335-40  -->
<!-- RWS May 2016: changed Level 3 to Level 2 because subtype is not always known. Will add comment to this effect. -->            
             <CONDITION>
                 98S
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 100I
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 101E
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 103HNST
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 106AM
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 181CI
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 188CHL
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 190ACEQSTV
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 230L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 138K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>

     <DRUG>
         <NAME>ETR</NAME>
         <FULLNAME>etravirine</FULLNAME>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 3 FROM 
                 (90I,98G,100I,101EHIPR,106I,179DFILMT,190AS,230L)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 138K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 181CIV
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 221Y
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 2 AND NOTMORETHAN 2 FROM 
                 (90I,98G,100I,101EHIPR,106I,179DFILMT,190AS,230L)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 138AGQRS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>
     <DRUG>
         <NAME>RPV</NAME>
         <FULLNAME>rilpivirine</FULLNAME>
         <RULE>
             <CONDITION>
                 101EP
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 138AGKQRS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 179L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 181CIV
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 188L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 221Y
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 227C
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 230ILV
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 100I AND 103NS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 100I AND 103R AND 179D
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
         	<CONDITION>
         		98G
         	</CONDITION>
         	<ACTIONS>
         		<LEVEL>2</LEVEL>
         	</ACTIONS>
         </RULE>
     </DRUG>
     <DRUG>
         <NAME>DOR</NAME>
         <FULLNAME>doravirine</FULLNAME>
         <RULE>
             <CONDITION>
                 106AM
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 188L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 190ES
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 230L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 100I AND 103N
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 103N AND 181C
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 103N AND 225H
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 227C
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 4 FROM 
                 (98G,100I,101E,106I,138K,181CV,190A,221Y)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 2 FROM 
                 (98G,100I,101E,106I,138K,181CV,190A,221Y)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>

<!-- ********** Begin PI drugs ********** -->

     <DRUG>
         <NAME>LPV/r</NAME>
         <FULLNAME>lopinavir/r</FULLNAME>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 4 FROM (10FIRV,20MR,24I,33F,46IL,50V,53L,54MLTV,63P,71ILVT,82AFST,84V,90M)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 47A
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 76V
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 3 AND NOTMORETHAN 3 FROM 
 					(10FIRV,20MR,24I,33F,46IL,50V,53L,54MLTV,63P,71ILVT,82AFST,84V,90M)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>

     <DRUG>
         <NAME>ATV/r</NAME>
         <FULLNAME>atazanavir/r</FULLNAME>
         <RULE>
             <CONDITION>
                 50L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 88S
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 3 FROM (10FIV,16E,33FIV,46IL,60E,71VT,84V,85V,90M)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 2 AND NOTMORETHAN 2 FROM (10FIV,16E,33FIV,46IL,60E,71VT,84V,85V,90M)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
         
     </DRUG>
     <DRUG>
         <NAME>DRV/r_QD</NAME>
         <FULLNAME>darunavir/r, 800/100mg QD</FULLNAME>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 2 FROM (11I,32I,33F,47V,50V,54LM,74P,76V,84V,89V)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>

     <DRUG>
         <NAME>DRV/r_BID</NAME>
         <FULLNAME>darunavir/r, 600/100mg BID</FULLNAME>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 4 FROM (11I,32I,33F,47V,50V,54LM,74P,76V,84V,89V)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
        
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 3 AND NOTMORETHAN 3 FROM (11I,32I,33F,47V,50V,54LM,74P,76V,84V,89V)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>     
     </DRUG>

<!-- ********** Begin EIGP41 drugs ********** -->

     <DRUG>
         <NAME>ENF</NAME>
         <FULLNAME>enfuvirtide</FULLNAME>
         <RULE>
             <CONDITION>
                 36ADESV
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 38AEKM
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 40HKPT
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 42DT
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 43DHKS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 44M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 45QM
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>

<!-- ********** Begin EIGP120 drugs ********** -->

     <DRUG>
         <NAME>FTR</NAME>
         <FULLNAME>fostemsavir</FULLNAME>
         <RULE>
             <CONDITION>
                 SELECT ATLEAST 1 FROM (375HIMNT,426LP,434IK,475I)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>

<!-- ********** Begin INSTI drugs ********** -->

     <DRUG>
         <NAME>RAL</NAME>
         <FULLNAME>raltegravir</FULLNAME>
         <RULE>
             <CONDITION>
                 66AK
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 92Q
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 118R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 121Y
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 140AS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 143ACGHRS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 144D
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 148EGHKR
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 155HST
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 157Q
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 230R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 263K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 74FI AND 75I
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         
     </DRUG>

     <DRUG>
         <NAME>EVG</NAME>
         <FULLNAME>elvitegravir</FULLNAME>
         <RULE>
             <CONDITION>
                 66AIK
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 92Q
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 97A
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 118R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 121Y
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 138K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 140ACS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 143ACGHRS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 144D
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 145S
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 147G
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 148EGHKR
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 155HST
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 157Q
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 230R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 263K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 74FI AND 75I
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>
     <DRUG>
         <NAME>DTG_QD</NAME>
         <FULLNAME>dolutegravir, 50mg QD</FULLNAME>
         <RULE>
             <CONDITION>
                 118R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 121Y
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 138AKT
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 140ACS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 144D
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 148HKR
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 153FY
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 155H
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 230R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 263K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 66K AND 74M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 74I AND 92Q
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
          <RULE>
             <CONDITION>
                 66K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>
     <DRUG>
         <NAME>DTG_BID</NAME>
         <FULLNAME>dolutegravir, 50mg BID</FULLNAME>
         <RULE>
             <CONDITION>
                 118R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 121Y
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 144D
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 153FY
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 263K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
	         66K AND 74M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
	         92Q AND 155H
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
	         148HKR AND SELECT ATLEAST 2 FROM (74I,97A,138AKT,140ACS)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
	         148HKR AND 155H
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         
          <RULE>
             <CONDITION>
	         	66K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
	         	 148HKR AND SELECT ATLEAST 1 AND NOTMORETHAN 1 FROM (74I,138AKT,140ACS)
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>

     </DRUG>
     <DRUG>
         <NAME>CAB</NAME>
         <FULLNAME>cabotegravir</FULLNAME>
         <RULE>
             <CONDITION>
                 118R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 121Y
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 138AKT
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 140ACRS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 144D
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 148HKR
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 153FY
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 155H
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 230R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 263K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 66K AND 74M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 74I AND 92Q
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
          <RULE>
             <CONDITION>
                 66K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>
     <DRUG>
         <NAME>BIC</NAME>
         <FULLNAME>bictegravir</FULLNAME>
         <RULE>
             <CONDITION>
                 118R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 121Y
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 138AKT
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 140ACS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 144D
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 148HKR
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 151L
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 153FY
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 155H
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 230R
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 263K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 66K AND 74M
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 74I AND 92Q
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
          <RULE>
             <CONDITION>
                 66K
             </CONDITION>
             <ACTIONS>
                 <LEVEL>2</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>
     <DRUG>
         <NAME>LEN</NAME>
         <FULLNAME>lenacapavir</FULLNAME>
         <RULE>
             <CONDITION>
                 56I
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 66I
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 67HKN
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 70HNRS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 74DS
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
         <RULE>
             <CONDITION>
                 107ACN
             </CONDITION>
             <ACTIONS>
                 <LEVEL>3</LEVEL>
             </ACTIONS>
         </RULE>
     </DRUG>
</ALGORITHM>

